Kaneka Eurogentec vs ST Pharm: CDMO Comparison
Side-by-side comparison of Kaneka Eurogentec and ST Pharm on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- ST Pharm has FDA inspections on record (2); Kaneka Eurogentec does not yet appear in the FDA inspection database.
On a 13-modality CDMO landscape, both Kaneka Eurogentec and ST Pharm qualify as mRNA/LNP manufacturers; Kaneka Eurogentec carries the higher composite Signal Score for mRNA/LNP programs in this comparison.
What to evaluate for mRNA/LNP programs
Both Kaneka Eurogentec and ST Pharm qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
Frequently asked: Kaneka Eurogentec vs ST Pharm
Which has the stronger FDA inspection record, Kaneka Eurogentec or ST Pharm?
Kaneka Eurogentec has 0 FDA inspections on record (NAI 0 / VAI 0 / OAI 0) and 0 warning letters. ST Pharm has 2 FDA inspections on record (NAI 0 / VAI 1 / OAI 1) and 0 warning letters.
How do Kaneka Eurogentec and ST Pharm compare on European GMP coverage?
Kaneka Eurogentec holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. ST Pharm holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for mRNA/LNP manufacturing — Kaneka Eurogentec or ST Pharm?
Both Kaneka Eurogentec and ST Pharm are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Kaneka Eurogentec carries a Signal Score of 80/100 and ST Pharm carries 73/100 — a small lead for Kaneka Eurogentec. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →